Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2009
12/10/2009WO2009101082A9 Substituted sulfonic acid amide compounds
12/10/2009WO2009095163A3 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals
12/10/2009WO2008146172A3 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
12/10/2009US20090306393 Process for preparing of, impurities free, substituted 2-benzimidazole-sulfoxide compound
12/10/2009US20090306389 Intermediate products for producing oxazolidinone-quinolone hybrids
12/10/2009US20090306383 Method for Producing 2-(4-Methyl-2-Phenylpiperazin-1-Yl)Pyridine-3-Methanol
12/10/2009US20090306382 Cationic alkoxyamines
12/10/2009US20090306372 Process for Making 3-Substituted 2-Amino-5-Halobenzamides
12/10/2009US20090306144 Pyridine derivatives of alkyl oxindoles as 5-ht7 receptor active agents
12/10/2009US20090306143 vanilloid receptor antagonists such as N-(1,2-Dimethyl-1H-benzimidazol-5-yl)-5-fluoro-1-(4,6-dimethylpyridin-2-yl)-1H-indole-2-carboxamide, used for the treatment of inflammation, psoriasis, pruritus, herpes, shingles, multiple sclerosis, metabolic, gastrointestinal and respiratory system disorders
12/10/2009US20090306141 Novel Compounds
12/10/2009US20090306140 3 or 4-Substituted Piperidine Compounds
12/10/2009US20090306139 Heteroaryl-substituted piperidines
12/10/2009US20090306138 chemokine receptor antagonists, such as 1-{3-[3-(4-fluorophenoxy)pyrrolidine-1-yl]propyl}-3-(3-methoxyphenyl)-urea, used as antiinflammatory agents
12/10/2009US20090306136 Benzenesulfonamide Compounds and the Use Thereof
12/10/2009US20090306134 Muscarinic receptor antagonists
12/10/2009US20090306133 New Acetyl Coenzyme A Carboxylase (ACC) Inhibitors And Uses In Treatments Of Obesity And Diabetes Mellitus - 087
12/10/2009US20090306110 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
12/10/2009US20090306109 Fungicide active substance combinations
12/10/2009US20090306108 Substituted pyrimidinones
12/10/2009US20090306103 Pyridonecarboxamide derivatives useful in treating hyper-proliferative and angiogenesis disorders
12/10/2009US20090306102 2-pyridin-2-yl-quinazoline derivatives as potassium channel modulating agents for the treatment of respiratory diseases
12/10/2009US20090306079 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
12/10/2009US20090306070 Tetra-o-substituted butane-bridge modified ndga derivatives, their synthesis and pharmaceutical use
12/10/2009US20090306059 Cyclic amine derivative having substituted alkyl group
12/10/2009US20090306053 Highly selective rho-kinase inhibitor
12/10/2009US20090306052 Indenyl derivatives and use thereof for the treatment of neurological disorders
12/10/2009US20090306048 Pharmaceutical use of substituted piperidine carboxamides
12/10/2009US20090306047 Heterocyclic aspartyl protease inhibitors
12/10/2009US20090306043 Pyrrolidine ether derivatives as nk3 receptor antagonists
12/10/2009US20090306042 Novel Compounds 010
12/10/2009US20090306041 Inhibitors of Bruton's tyrosine kinase
12/10/2009US20090306039 Compounds and compositions as itpkb inhibitors
12/10/2009US20090305998 Hsp90 inhibitors
12/10/2009US20090305433 Water-Soluble Rhodamine Dye Conjugates
12/10/2009US20090304632 HETEROCYCLIC NF-kB INHIBITORS
12/10/2009US20090302842 Biradical polarizing agents for dynamic nuclear polarization
12/10/2009CA2726588A1 Compounds and methods for treating inflammatory and fibrotic disorders
12/10/2009CA2726579A1 Novel uracil compound or salt thereof having human deoxyuridine triphosphatase inhibitory activity
12/10/2009CA2724878A1 3,4-dihydropyrimidine trpa1 antagonists
12/09/2009EP2130828A1 Sulfonamide derivative
12/09/2009EP2130827A1 Method for producing quinolone carboxylic acid derivative
12/09/2009EP2130822A1 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and mdm2 proteins for use as anticancer agents
12/09/2009EP2130820A1 Antipruritics
12/09/2009EP2130541A2 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
12/09/2009EP2130537A1 N3 alkylated benzimidazole derivatives as mek inhibitors
12/09/2009EP2130536A1 N3 alkylated benzimidazole derivatives as mek inhibitors
12/09/2009EP2130534A1 Use of ritonavir for improving the pharmacokinetics of drugs metabolized by cytochrome P450
12/09/2009EP2129669A1 Pyridinone derivative for the treatment of premature ejaculation
12/09/2009EP2129666A2 Development of molecular imaging probes for carbonic anhydrase-ix using click chemistry
12/09/2009EP2129222A1 Diaminopyrimidines as fungicides
12/09/2009EP1745040B1 Azabicyclo(3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors
12/09/2009EP1678172B1 Azabicyclic compounds for relieving pain and treating central nervous system disorders
12/09/2009EP1409450B1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
12/09/2009EP1020179B1 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition
12/09/2009CN101600711A Azetidine analogues of nucleosidase and phosphorylase inhibitors
12/09/2009CN101600710A Substituted dipyridyl-dihydropyrazolones and use thereof
12/09/2009CN101600709A Process for the preparation of a benzimidazole derivative
12/09/2009CN101600708A Organic compounds
12/09/2009CN101600707A Urea compounds useful in the treatment of cancer
12/09/2009CN101600706A Akt活性抑制剂 Akt activity inhibitor
12/09/2009CN101600705A Novel preparation method
12/09/2009CN101600697A New phenyl- (4-phenyl-pyrimidin-2-yl) - amines derivatives, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors
12/09/2009CN101600696A Substituted arylpyrazoles
12/09/2009CN101600692A Stable S-nitrosothiols, method of synthesis and use
12/09/2009CN101600691A Piperidinyl derivatives as modulators of chemokine receptor activity
12/09/2009CN101600682A Process for making 3-substituted 2-amino-5-halobenzamides
12/09/2009CN101597280A Compound used as seven-pass transmembrane protein and based on sag structure
12/09/2009CN101597278A Amide-type compound as well as preparation method and application thereof
12/09/2009CN101597277A Novel method for preparing S-pantoprazole and salt
12/09/2009CN101597262A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
12/09/2009CN101597259A Organic material and application thereof in organic electroluminescence device (OELD)
12/09/2009CN101596191A Method for treatment of disease using malonyl-coa decarboxylase inhibitor
12/09/2009CN100567293C N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists
12/09/2009CN100567292C Diastereoselective synthesis process for the preparation of imidazole compounds
12/09/2009CN100567291C Diastereoselective synthesis process with 6-bromo-4-(3-chlorophenyl)-2-methoxy-quinoline
12/09/2009CN100567290C Diastereoselective addition of lithiated N-methylimidazole on sulfinimines
12/09/2009CN100567289C 2-(hetero)aryl substituted tetrahydroquinoline derivatives
12/09/2009CN100567288C 4-tetrazolyl-4-phenylpiperidine derivatives for treating pain
12/09/2009CN100567268C Process for synthesis of amine ethers from secondary amino oxides
12/09/2009CN100567266C Cannabinoid receptor ligands
12/08/2009US7629468 Neuroprotectants, analgesics or anticonvulsants
12/08/2009US7629463 Pesticides that are more effective, less costly, less toxic, environmentally safer; 1-(2-chloromethyl-N-[2-methyl-6-(1-methyl-1H-imidazol-2-yl)phenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide
12/08/2009US7629369 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation
12/08/2009US7629363 Diaryl substituted pyridinones
12/08/2009US7629362 2-pyridine carboxamide derivatives
12/08/2009US7629361 Salt of (S)-pantoprazole and its hydrates
12/08/2009US7629357 Antihypoxic agents; adjust concentration of erythropoietin concentration in blood; strokes; antiepileptic agents; neurodegenerative disease ; liver disorders; antiischemic agents
12/08/2009US7629348 Insecticides; for human or veterinary medicine
12/08/2009US7629347 Modulating and/or regulating signal transduction of both receptor-type and non-receptor type tyrosine kinases; cancer; chronic myelogic leukemia
12/08/2009US7629343 Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitors
12/08/2009US7629341 Human ADAM-10 inhibitors
12/08/2009US7629340 N-(6-membered aromatic ring)-amido anti-viral compounds
12/08/2009US7629339 inhibitors of protein kinases and are useful in treating cancer; 4-({5-[5-Fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carbonyl}-amino)-3-methoxy-butyric acid; anticarcinogenic agent
12/08/2009US7629338 for treating migraine, headaches; N-[(4S)-3-Methyl-2,5-dioxo-1',3'-dihydrospiro[imidazolidine-4,2'-inden]-5'-yl]-2-((6+-)-2-oxo-6-phenylpiperidin-1-yl)acetamide
12/08/2009US7629337 Chemokine receptor binding heterocyclic compounds
12/08/2009US7629336 Biphenyl compounds useful as muscarinic receptor antagonists
12/08/2009CA2422354C Pyrazole compounds useful as protein kinase inhibitors
12/08/2009CA2422342C Novel amide derivatives and medicinal use thereof
12/08/2009CA2415486C Pyramidine derivatives
1 ... 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 ... 1080